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Long QT syndrome (LQTS) is a congenital abnormality of cardiac repolarization that
manifests as a prolonged QT interval on 12-lead electrocardiograms (ECGs). The syndrome
may lead to syncope and sudden death from ventricular tachyarrhythmias known as
torsades de pointes. An increased persistent Na+ current is known to cause a Ca2+
overload in case of ischemia for example. Such increased Na+ persistent current is also
usually associated to the LQT3 syndrome. The purpose of this study was to investigate the
pathological consequences of a novel mutation in a family affected by LQTS. The impact
of biophysical defects on cellular homeostasis are also investigated. Genomic DNA was
extracted from blood samples, and a combination of PCR and DNA sequencing of several
LQTS-linked genes was used to identify mutations. The mutation was reproduced in vitro
and was characterized using the patch clamp technique and in silico quantitative analysis.
A novel mutation (Q1476R) was identified on the SCN5A gene encoding the cardiac Na+
channel. Cells expressing the Q1476R mutation exhibited biophysical alterations, including
a shift of SS inactivation and a significant increase in the persistent Na+ current. The
in silico analysis confirmed the arrhythmogenic character of the Q1476R mutation. It
further revealed that the increase in persistent Na+ current causes a frequency-dependent
Na+ overload in cardiomyocytes co-expressing WT and mutant Nav1.5 channels that, in
turn, exerts a moderating effect on the lengthening of the action potential (AP) duration
caused by the mutation. The Q1476R mutation in SCN5A results in a three-fold increase
in the window current and a persistent inward Na+ current. These biophysical defects
may expose the carrier of the mutation to arrhythmias that occur preferentially in the
patient at rest or during tachycardia. However, the Na+ overload counterbalances the
gain-of-function of the mutation and is beneficial in that it prevents severe arrhythmias
at intermediate heart rates.
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INTRODUCTION
In cardiomyocytes, action potentials (AP) ensure the propagation
of excitation and the triggering of contraction. AP characteristics
are directly related to the activity of voltage-gated sodium (Na+),
calcium (Ca2+), and potassium (K+) channels (Amin et al.,
2010). After a slight depolarization, voltage-gated Na+ channels
(Nav1.5), encoded by the SCN5A gene, activate, which leads to an
inward Na+ flow followed by a fast depolarization (Gellens et al.,
1992). The AP is composed of a maintained depolarization, the
“plateau” phase, followed by a final repolarization. The depolar-
ization at the plateau is supported by a slowly decaying inward
calcium current, background inward currents, and a persistent
sodium current. The plateau is also supported by a delay in the
onset of repolarizing potassium currents. The late activation of
these potassium currents ensures final repolarization and causes
the membrane potential to return to the diastolic level after about
400ms. The maintenance of action potential duration (APD) is
critically related to the balance between depolarizing currents
and repolarizing currents, so that an increase in depolarizing
current(s) or a decrease in repolarizing current(s) will increase
APD and, consequently, the QT interval of the electrocardiogram
(ECG).
Long QT syndrome (LQTS) includes a congenital abnor-
mality of cardiac repolarization that causes syncope and sud-
den death (Huang et al., 2011). This hereditary cardiac disease
manifests as an increase in the QTc value over 450ms on 12-
lead ECGs, which points to an increase in the duration of
ventricular APs. Under optimal conditions, QTc prolongation
can induce ventricular tachyarrhythmia called torsade de pointes
(TdP), which can degenerate into lethal ventricular fibrillation.
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To date, mutations in thirteen genes have been identified as
causing 13 types of LQTS (LQT1-13) (Schwartz et al., 2012)
and are divided into three major groups: (1) mutations in
genes encoding voltage-gated channels [KCNQ1 (LQT1), KCNH2
(LQT2), SCN5A (LQT3), KCNJ2 (LQT7), KCNJ5 (LQT13)],
(2) mutations in genes encoding subunits regulating voltage-
gated channel [KCNE1 (LQT5), KCNE2 (LQT6), SCN4B (LQT
10)], and (3) mutations in genes encoding channel interact-
ing proteins [ANKB (LQT4), KCNE1 (LQT5), KCNE2 (LQT6),
CAV3 (LQT9)].
SCN5A gene mutations can lead to several inherited cardiac
diseases such as LQT3, Brugada syndrome (BrS) (Moreau et al.,
2012), progressive cardiac conduction defect (CCD), sinus node
disease, and dilated cardiomyopathy (DCM) (Amin et al., 2010;
Gosselin-Badaroudine et al., 2012). In LQT3, a gain-of-function
mediated by the appearance of a persistent current usually char-
acterizes Na+ channel mutations. The persistent Na+ current has
previously been shown to induce Ca2+ overload (Tang et al.,
2012). Indeed, in hypoxia condition, the persistent Na+ cur-
rent is increased and have been identified as a predominant
cause of the deleterous Ca2+ overload (Tang et al., 2012). Such
phenomenon could be important in the development of LQT3
syndrome and would be driven by the activation of Na+/H+
and Na+/Ca2+ exchangers. These exchangers are predominantly
implicated in the Ca2+, Na+, and pH regulation. However,
most mutations in K+ channels or their regulatory subunits
cause a loss-of-function characterized by a dominant negative
effect. These biophysical defects lead to AP prolongation, creat-
ing a substrate for the development of ventricular arrhythmias
(Schwartz et al., 2012).
The purpose of our study was to investigate the impact of a
mutation causing LQTS in a patient and her family members
using an in vitro heterologous expression system, the voltage-
clamp technique, and in silico analysis. The biophysical investi-
gation of the mutation in tsA201 cells revealed a positive shift in
steady-state (SS) inactivation that results in an increased window
current associated with the presence of a persistent Na+ current,
which would explain the link between the mutation and LQTS in
the family members. Furthermore, in silico experiments revealed
that the persistent Na+ current induces an increase in the intracel-
lular Na+ concentration. This causes an increase in repolarizing
currents that shortens APD, counterbalancing the direct effect




The proband and her family members underwent a detailed clin-
ical and cardiovascular examination, including a 12-lead ECG,
a determination of hemodynamic parameters, and laboratory
blood tests. Echocardiography was used to exclude any structural
heart disease. The QT interval was measured in lead II or V5 of
the ECG and was corrected for the heart rate (QTc) using Bazett’s
formula. Exercise testing was performed to detect QT adaptation
to heart rate changes, which is known to predict the genotype
and direct therapy in LQTS (Schwartz et al., 2001; Wong et al.,
2010).
The investigation conformed to the principles set out in the
Declaration of Helsinki and was approved by the local institu-
tional ethics committees on human subject research. The partici-
pants provided written informed consent prior to the study.
GENOTYPING
The samples were sent to Genaissance Familion® (New Haven,
CT, USA) for genetic testing of inherited cardiac syndromes.
Genomic DNA was extracted and was amplified by PCR.
Templates of the target exons, splice junctions, and flanking
regions of KCNQ1 (LQT1), KCNH2 (LQT2), SCN5A (LQT3),
KCNE1 (LQT5), KCNE2 (LQT6), CACNA1C (LQT8, exons 8 and
9), CAV3 (LQT 9), SCN4B (LQT 10), AKAP9 (LQT 11, exon 18),
and SNT12 (LQT 12) were generated and genotyped.
MUTAGENESIS
Mutant Nav1.5/Q1476R was generated using QuickChange
TM site-directed mutagenesis kits according to the manu-
facturer’s instructions (Stratagene, La Jolla, CA, USA). The
hNav1.5/mutants were constructed from WT channels (NCBI
accession number: M77235) using the following mutagenic sense
and antisense primers (mutated sites are underlined):
1. 5′-CAACTTCAACCAACGGAAGAAAAAGTTAGGG-3′
2. 5′-CCCTAACTTTTTCTTCCGTTGGTTGAAGTTG-3′
Mutant and the wild-type (WT) Nav1.5 in a pcDNA3 construct
were purified using Qiagen columns (Qiagen Inc., Chatsworth,
CA, USA).
TRANSFECTION OF THE tsA201 CELL LINE
TsA201 is a mammalian cell line derived from human embry-
onic kidney HEK 293 cells by stable transfection with SV40
large T antigen (Margolskee et al., 1993). The tsA201 cells were
grown in high glucose DMEM supplemented with fetal bovine
serum (10%), L-glutamine (2mmol/L), penicillin (100 U/ml),
and streptomycin (10mg/ml) (Gibco BRL Life Technologies,
Burlington, ON, Canada) and were incubated in a 5% CO2
humidified atmosphere. The cells were transfected using the
calcium phosphate method (Margolskee et al., 1993), with the
following modification to facilitate the identification of indi-
vidual transfected cells: the cells were co-transfected with an
expression plasmid for a lymphocyte surface antigen (CD8-a)
(Jurman et al., 1994). The human Na+ channel β1 subunit and
CD8 were constructed in the piRES vector (piRES/CD8/β1). With
this strategy, transfected cells that bind beads also express the
β1-subunit. cDNA (5μg) coding for the WT or mutant Na+
channel α-subunit and 5μg of piRES/CD8/β1 were used. For
the patch clamp experiments, 2 to 3-day-post-transfection cells
were incubated for 5min in a medium containing anti-CD8-a
coated beads (Jurman et al., 1994) (Dynabeads M-450 CD8-a).
Unattached beads were removed by washing. The beads were pre-
pared according to the manufacturer’s instructions (Dynal A.S.,
Oslo, Norway). Cells expressing surface CD8-a fixed the beads
and were visually distinguishable from non-transfected cells by
light microscopy.
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PATCH CLAMP TECHNIQUE
Macroscopic Na+ currents from tsA201-transfected cells were
recorded using the whole-cell configuration of the patch clamp
technique (Hamill et al., 1981). Patch electrodes were made from
8161 Corning borosilicate glass and were coated with HIPEC
(Dow-Corning, Midland, MI, USA) to minimize their capaci-
tance. Patch-clamp recordings were made using low resistance
electrodes (<1M), and a routine series resistance compensa-
tion by an Axopatch 200 amplifier (Axon Instruments, Foster
City, CA, USA) was performed to values >80% to minimize
voltage-clamp errors. Voltage-clamp command pulses were gen-
erated by microcomputer using pCLAMP software v10.0 (Axon
Instruments). Na+ currents were filtered at 5 kHz, digitized at
10 kHz, and stored on a microcomputer equipped with an AD
converter (Digidata 1300, Axon Instruments).
SOLUTIONS AND REAGENTS
For whole cell recordings, the patch pipette contained (in
mmol/L): 35 NaCl, 105 CsF, 10 EGTA, and 10 Cs-HEPES. The pH
was adjusted to 7.4 using 1N CsOH. The bath solution contained
(inmmol/L) 150 NaCl, 2 KCl, 1.5 CaCl2, 1MgCl2, 10 glucose, and
10 Na-HEPES. The pH was adjusted to 7.4 with 1 N NaOH. The
recordings were made 5min after establishing the whole cell con-
figuration to allow the current to stabilize and to permit adequate
diffusion of the contents of the patch electrode. All the recordings
were made in the following order: I/V curve, SS inactivation, and
recovery from inactivation. Experiments were carried out at room
temperature (22–23◦C).
In silico analysis and AP modeling
The Priebe and Beuckelmann (1998) (PB), the Iyer et al. (2004)
(IMW) model and the Ten Tusscher et al. (2004) (TNNP) mod-
els were considered as possible alternatives to represent human
ventricular myocyte (Priebe and Beuckelmann, 1998; Iyer et al.,
2004; Ten Tusscher et al., 2004). A comparison of these models
was done by Ten Tusscher et al. in 2006 and it showed that the
TNNP model was the most pertinent to reproduce the effects of
IKr and IKs block on the human ventricular AP duration (Ten
Tusscher et al., 2006). We considered it as a valid model to address
changes related to LQT conditions. Besides, rather than using
Markov models, this model is based on Hodgkin–Huxley equa-
tions, which are easy to adjust to known experimental data (Fink
and Noble, 2009).
Thus, the in silico analysis was performed with the Ten
Tusscher et al. (2004) model (Ten Tusscher et al., 2004), using the
tentusscher_noble_noble_panfilov_2004_a.cellml file, ran in the
COR environment (Peter Garny, http://cor.physiol.ox.ac.uk/).
Changes from the original set of equations are described in the
Appendix.
When we attempted to modify the activation and inactiva-
tion parameters of the Na+ current (INa) in the original TNNP
model, instabilities were found, which could not be resolved.
Thus, the mathematical equations used for activation, inactiva-
tion, and recovery from inactivation of INa were taken from a
stable guinea-pig ventricular cell model adjusted for 37◦C (Pasek
et al., 2008). However, the processes were accelerated two-fold
(the time constants were reduced two-fold). This was done to
allow the model to reproduce the experimentally observed Na+
currents when we ran, in the model set for room temperature, the
same voltage-clamp protocols as used in our in vitro experiments.
To adapt to the formalism of the Na+ current (INa) calcu-
lation that uses m3, the measured values of the SS apparent
activation variable measured in tsA201 cells were fitted with the
following equation: minf = [1/(1 + exp((Vm − Vh)/k))]3, which
yielded values of Vh = −59.1mV and k = −7.9mV for WT and
Vh = −56.8mV and k = −8.7mV for Q1476R. This explains
why these values of Vh and k were different from those calcu-
lated by fitting a simple Boltzmann function to data measured in
tsA201 cells (Table 1).
Lastly, 5.5mV was added to Vh and 0.5mV to k to account
for the difference in temperature given that the experiment was
conducted at room temperature whereas the model was designed
to work at 33◦C, such thatVh = −59.1 + 5.5 and k = −7.9 + 0.5
for WT and Vh = −56.8 + 5.5 and k = −8.7 + 0.5 for Q1476R.
The SS inactivation functions were hinf = 1/(1 + exp((Vm −
Vh)/k)), where Vh = −92.0 + 5.5 and k = 4.4 for WT, and Vh =
−86.1 + 5.5 and k = 4.3 for Q1476R. In addition, 5.5mV was
added to Vh to account for the difference in temperature.
This adjustment of the kinetic parameters was derived from
the detailed analysis of the effects of temperature on the activation
and inactivation kinetics of Nav1.5 channels by Nagatomo et al.
(1998). It reflects a change in temperature from 23 to 33◦C. A lin-
ear extrapolation to 37◦C could have been done. Nevertheless, no
differences should be observed as these corrections would apply
to both WT and mutated fast INa model equations.
The modeling of the heterozygous condition is based on the
assumption that, in the carrier, both the WT and the mutated
genes would lead to the presence of equal amounts of each cor-
responding channel protein. Thus, half of the fast Na+ current
is characterized by the parameters of the WT channels while the
second half is characterized by the parameters of the Q1476R
channels.
The persistent part of the fast Na+ current was initially absent
in the TNNP model. A persistent current was added that would
not inactivate but that would activate and deactivate following
Table 1 | Biophysical properties of Nav1.5/WT and Q14767R.
WT (n = 13) Q1476R (n = 14)
Peak current (pA/pF) −739.1 ± 73.1 −690.8 ± 69.9
Persistent current (% I Na+) 0.36 ± 0.08 0.74 ± 0.11*
Activation V1/2 (mV) −47.9 ± 1.2 −46.3 ± 1.1
k (mV) −5.6 ± 1.2 −6.5 ± 0.4
Inactivation V1/2 (mV) −92.0 ± 1.3 −85.5 ± 0.4*
k (mV) 4.4 ± 0.1 4.3 ± 0.1
Recovery from fast
inactivation
A 99.9 ± 0.05 98.7 ± 1.1
Tau 2.7 ± 0.1 2.2 ± 0.3
V1/2, Mid-point for activation or inactivation.
k, Slope factor for activation or inactivation.
*Difference between Nav 1.5/WT and Nav 1.5/Q1476R (p < 0.05).
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the same equations as the fast Na+ current (see equations in the
Appendix).
Initially, the model was run with the basic set of values of vari-
ables and constants as used in the TNNP 2004a model, except for
the formulation of INa, as described above. The APD90 was mea-
sured as the time between upstroke and 90% repolarization from
the highest level of the plateau. No attempt was made to readjust
the APD90 at SS at 1Hz, which was increased from 322ms in the
original TNNP model to 454ms for our WT settings.
Voltage-clamp testing was performed using MATLAB to show
that the basic properties of the fast INa current, the persistent Na+
current and the window current, adjusted for room temperature,
matched those of the WT and mutated currents as determined
in the expression experiments when using the same protocols
and measurement procedures in the presence of a realistic series
resistance (not shown).
Based on our previous modeling experience with a persistent
INa (Christe et al., 2008), it was necessary to allow the model to
stabilize with a small amount of persistent INa before increasing
the persistent INa until reaching at most one-third of the frac-
tion of the fast peak INa observed in expression experiments. This
was the maximal amount of persistent INa tolerated by the het-
erozygous mutation model in order to ensure that a stable AP was
generated at 1 and 1.5Hz.
DATA ANALYSIS AND STATISTICS
The electrophysiological data were analyzed using macros
in Clampfit (pCLAMP v10.0, Molecular Devices) and cus-
tom programs written using MATLAB (The MathWorks Inc.).
Data are expressed as means ± sem (standard error of the
mean). Statistical comparison were performed using an unpaired
Student’s t-test or One-Way Anova with Bonferroni post-hoc
test in Sigma plot (Jandel Scientific software). Differences were
deemed significant at a P-value < 0.05.
RESULTS
CLINICAL CHARACTERISTICS OF THE INDEX PATIENT AND THE FAMILY
MEMBERS
A 34-year-old female was assessed, in the context of a family
history of sudden death, for a remote history of syncope after
awakening to answer the telephone. Her sister had experienced a
series of similar episodes at age 14 and had subsequently collapsed
at rest and could not be resuscitated. The autopsy did not reveal
a cause of death. A maternal cousin and grandaunt also experi-
enced sudden death (Figure 1A). The resting QTc of the proband
ranged from 450 to 485ms and shortened to 422ms at peak exer-
cise. The echocardiogram was normal. Nadolol 40mg once daily
and mexiletine 200mg twice daily were initiated. While mexile-
tine shortened the QTc (Figure 1B), it was discontinued before
reassessment because of side effects. We identified an A-to-G base
change at nucleotide position 5300 in exon 25 on the SCN5A
gene by PCR and DNA sequencing. The base change led to a
glutamine (Q)-to-arginine (R) substitution at residue 1476. The
Q1476 residue is in a region of the SCN5A gene/Nav1.5 pro-
tein in Na+ channels (Figure 2A) that has been extraordinarily
highly conserved throughout evolution, from humans to zebra
fish (not shown). Another highly conserved glutamine (Q1475,
FIGURE 1 | Family pedigree and 12-lead ECG of the proband. (A) Family
pedigree. Subjects II-2 and III-2 and III-3 with the LQT3 phenotype (black
circle and square), the arrow indicates the proband. (B) Twelve-lead ECG.
Baseline ECG in the proband, demonstrating a long isoelectric ST segment,
followed by a deferred T was with normal morphology. The second ECG
represents a repeat ECG after 2 doses of 200mg of mexilitine. The ECGs of
her affected and unaffected daughter are also presented. Voltage scale:
0.5mV/large square, time scale: 0.2 s/large square.
Figure 2A) was located upstream from the Q1476 residue. The
mutation occurred in an important region of the Na+ channel
known as the inactivation gate (Figure 2B). An H558R polymor-
phism was associated with the novel Q1476R mutation. The four
children of the index patient were examined and presented QTc
values of 414, 444, 480, and 502ms. Three of them underwent an
exercise test and their QTc values went from 444 to 442ms, 480 to
500ms, and 502 to 522ms, respectively. The two who presented
with borderline QTc prolongation were subsequently confirmed
to be carrying the Q1476R variant. The index patient remained
free of symptoms during the 5-year follow-up period.
BIOPHYSICAL CHARACTERIZATION
We investigated whether the novel mutation caused an alter-
ation of the biophysical properties of the Nav1.5 Na+ chan-
nel that would explain the clinical phenotype of the index
patient. Macroscopic Na+ currents were recorded from tsA201
cells expressing either WT (Nav1.5/WT) or mutant channels
(Nav1.5/Q1476R) co-transfected with the regulatory β1-subunit
(see Methods for more details) (Figure 3A). The mutant Na+
channel current exhibited no significant shift in the current-
voltage (I/V) relationship, and the current density was similar
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FIGURE 2 | Q1476 is within a highly conserved region. (A) Amino
acid alignments of the region between transmembrane domains IIIS6
and IVS1 (III-IV linker) showing in red that glutamine 1475 and
glutamine 1476 are highly conserved in human voltage-gated sodium
channels. The IFM inactivation particle is displayed in red. (B) Schematic
representation of the Nav1.5 channel structure displaying voltage
sensitive domains, the segments forming the pore domain, and the
inactivation gate. Q1475 and Q1476 are also indicated. The missense
mutation of one these two amino acids leads to several pathologies,
depending on the channel impacted. The mutation of Q1475 in Nav1.1
causes familial hemiplegic migraine (FHM), whereas the mutation of
Q1476 in Nav1.5 causes LQT3 syndrome.
to that of the WT channel (WT: −739.1 ± 73.1 pA/pF, Q1476R:
−690.8 ± 69.9 pA/pF) (Figure 3B, Table 1). This result is based
on the measurement of the peak current which is defined as
the maximal absolute current obtained with the stimulation pro-
tocol (see Figure 3 legend). This peak current corresponds to
the value where the global conductance reaches its maximum.
A small persistent Na+ current was recorded. The persistent
Na+ current was investigated using a 400ms two-pulse pro-
tocol, and it was measured as mean of the current between
100 and 350ms. The magnitude of this persistent current was
significantly (p < 0.05) different from that recorded from WT
channels at −30mV (0.36 ± 0.08%, n = 13 for WT channels,
0.74 ± 0.11%, n = 14 for mutant channels) (Figure 3C, Table 1).
SS activation (Gv) and inactivation curves were also studied
(Figure 3D, Table 1). The Gv curve of the mutant Na+ channel
showed no significant shift (p = 0.340 for V1/2 and p = 0.081 for
the slope factor). However, there was a 6.5mV (p < 0.05) shift
in the SS inactivation curve toward more positive voltages for
the Q1764R mutant channel (V1/2 Nav1.5/Q1476R = −85.5 ±
0.4mV, n = 14 vs. V1/2 Nav1.5/WT = −92.0 ± 1.3mV, n = 13).
The slope factor was not significantly affected (p = 0.544). The
mutation did not induce any significant changes in the time
course of the Na+ current decay or the recovery from inactivation
(Figure 4).
The overlap of SS activation and inactivation of Na+ channels
defines a range of voltages (i.e., window) where Na+ channels
open, resulting in an inward Na+ current that could potentially
depolarize the resting membrane potential and increase myocyte
excitability. The Q1476R mutation induced an increase in the
overlap of Na+ channel activation and inactivation by shifting
the inactivation to more positive potentials. This shift tended to
expand the window and thus, the fraction of permanently acti-
vated channels. Figure 5A shows the predicted window currents
of the WT and Q1476R mutant Nav1.5 channels. The Q1476R
mutation produced a ∼7-fold increase in the Nav1.5 window
current, suggesting that more channels had reopened within the
window region. Figure 5B shows the increase in the window cur-
rent together with the increase in the perisistent component,
suggesting that Q1476R had a higher probability to open at
voltages ranging from −140 to +20mV.
The persistent Na+ current can be attributed to the Nav1.5
channel as it was blocked (0.06 ± 0.06%, n = 5) by 10μM of
tetrodotoxin, a Na+ channel blocker (Figure 6). Mexiletine was
seen to be efficient to treat the patient. The effect of this class
I B antiarrhythmic was thus tested on the persistent Na+ cur-
rent. 50μMofmexiletine importantly reduced the persistent Na+
current (0.09 ± 0.03%, n = 5) (Figure 6).
IN SILICO CHARACTERIZATION OF THE CHANGES INDUCED BY THE
HETEROZYGOUS MUTATION Q1476R
The in silico characterization incorporates the heterozygous
aspect of the mutation. This model is used to observe the effects
of the mutation on several parameters including AP, Na+ window
current INa (the large inward current surge simultaneous with
AP upstroke is largely off scale), persistent Na+ current (INap),
Na+ and Ca2+ intracellular concentrations (Nai and Cai). As a
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FIGURE 3 | Biophysical characterization of Nav1.5/WT and the
Q1476R mutant channels. (A) Representative whole-cell current
traces of the WT (left) and Q1476R (right) channels. Currents were
elicited using a voltage-clamp protocol where depolarizing pulses
were applied for 50ms from −100 to +80mV in 5mV increments
(see protocol in inset). The zero current corresponds to the basal
line shown at the beginning of each trace. (B) After normalization to
cell capacitance, current-voltage (I-V) relationships were constructed
for the Nav1.5/WT (n = 13, black) and Q1476R (n = 14, red) channels.
(C) Representative current traces obtained after a −30mV
depolarizing pulse showing INap. The Nav1.5/WT channel trace is
depicted in black while the Nav1.5/Q1476R channel trace is depicted
in red. (D) Voltage dependence of SS activation (circles) or
inactivation (squares) for the WT (black) and Q1476R (red) Nav1.5
Nav1.5 channels. A standard Boltzmann function was used to fit
activation curves and to obtain the V1/2 and given in Table 1
[G(V )/Gmax = 1/(1 + exp(−(V − V1/2)/k))]. Inactivation currents were
obtained by applying conditioning pre-pulses to membrane potentials
ranging from a holding potential of −140 to −10mV for 500ms in
5mV increments and were then measured using a 4-ms pulse to
−30mV at each step (see protocol in inset). The recorded
inactivation values were fitted to a standard Boltzmann equation
[I(V )/Imax = 1/(1 + exp((V − V1/2)/k)) + C] to obtain the values given
in Table 1.
rule, model simulations were conducted for at least a 2000 s cell
lifetime to ensure that SS in all variables was reached.
With 1-Hz stimulations, at SS, the WTmodel shows an APD90
of 454ms and a Nai of 11.94mmol/L (central column, trace a,
in Figure 7A, and Table 2). The model was then changed to the
heterozygous condition (denoted as WR), with half of the INa
current being WT and half being Q1476R. The first AP obtained
in the WR condition had an APD90 of 587ms (trace b) without
appreciable change in Nai. Both Na+ window current and INap
amplitudes were increased when the mutation was introduced
(2nd and 3rd panels from the top, respectively, central column
of Figure 7A). This was consistent with estimates computed from
the voltage-clamp data (Figure 5). The difference is that the mag-
nitude of the mutation-induced increase in the window current
and in the INap as evaluated in the heterozygous model was
two-fold less than that reported in Table 1, since, in the WR
model, only half of the current is of the mutated type. When
running this heterozygous model to SS (trace c), Nai expect-
edly increased, reaching 12.92mmol/L, while APD90 shortened
to 513ms. The diastolic Cai and Cai transients were also increased
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FIGURE 4 | Time constants of inactivation and of recovery from
inactivation. (A) Curves representing the time constant of inactivation as a
function of the voltage for the WT and Q1476R channels. A two-exponential
function was used to fit the inactivation curves observed on whole cell
current traces: I = Afast(exp[−(t − k)/τfast]) + Aslow(exp[−(t − k)/τslow]
+C), where Afast and Aslow are fractions of recovery of the fast and slow
components, t is time, and k is the delay factor for activation or inactivation.
τfast and τslow were obtained from the equation from −50 to +20mV for
the Nav1.5/WT and Q1476R channels. (B) Recovery from fast inactivation of
the WT (black) and Q1476R (red) channels. Curves were obtained using the
two-pulse protocol shown in the inset. The pulses (+30mV) induced
maximal activation, and the time interval between pulses represents the
time needed to obtain a re-activation. The recorded recovery from
inactivation values were fitted to a single exponential equation
[A∗(1 − exp(−x/τ) + C)] to obtain the values given in Table 1.
(Figure 7A, lower panel, central column and Table 2). The instan-
taneous APD90 lengthening by 29% due to changing from WT to
WR condition was reduced to 13% vs. WT when the WR model
reached SS. Most of the lengthening was thus counterbalanced
by changes that occurred during regular stimulations for longer
periods (typically 2000 s).
The same simulations were conducted at 1.5Hz until SS
(Figure 7A, 3rd column, and Table 2). APD90 and Nai, respec-
tively stabilized at 392ms and 13.59mmol/L for WT (trace a).
After the switch to the WR model, the first AP (trace b) had
an APD90 of 471ms (Nai remained unchanged). After reach-
ing SS (trace c), APD90 shortened to 436ms and Nai increased
to 14.57mmol/L. At SS, the diastolic Cai and Cai transients
had increased in the WR model. The increases were larger than
FIGURE 5 | Nav1.5/WT and Q1476R window currents. (A) The window
current is defined as the overlap between activation and inactivation. The
window current was obtained using the following equation: (1/(1 +
exp((V1/2activation − V )/kactivation)) × ((1 − C)/(1 + exp((V − V1/2inactivation)/
kinactivation)) + C). (B) The INap component was added to the window
current of the WT or the Q1476R channel.
those seen at 1Hz (Figure 7A, lower panel, 3rd column and
Table 2).
To test the effect of bradycardia, the stimulation rate was
lowered from 1Hz to 0.5Hz. At SS, the WT model had
a longer APD90 (558ms) and a lower Nai (9.84mmol/L)
than at 1Hz. In the WR model at 0.5Hz, APD90 and Nai
reached SS values of 705ms and 10.95mmol/L (Table 3), while
the diastolic Cai and Cai transients decreased (Figure 7A,
1st column, lower panel and Table 3). To determine the
effect of changes in Nai on APD90, changes in Nai were
applied instantaneously to the model in several settings
(Figure 7B).
In the WTmodel, from SS at 1Hz, setting Nai to its value at SS
at 0.5Hz produced an APD90 of 542ms (Figure 7B, left panel).
This was comparable to the SS APD90 at 0.5Hz when Nai was
not imposed (558ms). Likewise, when SS Nai was imposed in
the WR model at 0.5 and 1Hz, the APD90s of the next AP were
respectively 683 and 515ms, vs. 705 and 513ms at SS when Nai
was not imposed (left panel of Figure 7B and Table 3). At 1Hz,
in WR model under SS, changing Nai to WT SS value produced
APD90 of 582ms. This value is close to that of the first WR AP
(APD90 of 587ms). Then, changing to WT produced APD90 of
451ms which is similar to SS WT APD90 of 454ms (middle panel
of Figure 7B and Table 1). At 1.5Hz (Figure 7B, right panel and
Table 2), APD90 produced by changing Nai values were very close
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FIGURE 6 | Effect of Na+ channel blockers on the INap.
(A) Representative current traces obtained after a −30mV depolarizing
pulse showing INap before and after drug treatment. The Nav1.5/Q1476R
traces are depicted in black while the traces after treatment are shown in
red for mexiletine (50μM, left) and blue for TTX (10μM, right). (B)
Histogram of INap. The INap accounted for 0.36 ± 0.08% (n = 13, red
column) of the peak current for WT channel and 0.74 ± 0.11% (n = 14,
orange column) for Q1476R channels (#p = 0.015 when compared to WT
channels). The treatment with 50μM of mexiletine or 10μM of TTX,
respectively reduced the INap to 0.09 ± 0.03% (n = 5, green column,
∗∗p = 0.002) and 0.06 ± 0.06% (n = 5, gray column, ∗∗∗p = 0.001). After
treatment, no differences were observed with WT channels. “#” indicate
statistical differences when compared to WT channels, “∗” indicate
statistical differences when compared to Q1476R channels.
to those in the original simulations at SS. Thus, applying solely
Nai changes reproduced most of the APD90 decrease observed at
SS.
In the TNNP 2004 model, the only two ion transfer mecha-
nisms that depend on Nai are the Na+-K+ pump (INaK) and
the Na+-Ca2+ exchanger (INaCa) (Ten Tusscher et al., 2004).
Their activity increase when Nai is increased. In Figure 8A, the
two upper panels are a repeat of the first and third panels from
the top in the middle column of Figure 7. The lower panel
of Figure 8A is new and reports the time course of the INaK
and INaCa currents during an AP. There was a large immediate
increase in the duration of the first AP recorded after switching
the model to the WR condition (Figure 8A upper panel, com-
pare traces a and b). This was a direct effect of the increase in
the conductance of the INap (middle panel, blue vs. black trace).
The magnitudes of the INaK and the INaCa exchanger currents
followed the changes in the membrane potential (compare blue
and black traces in the lower panel). We further stimulated the
model at 1Hz until SS. The APD90 shortened (Figure 8A upper
panel, trace c, orange line). While the changes in INap magnitude
just followed the changes in membrane voltage values (orange vs.
blue trace, middle panel), the magnitudes of both the INaK and
the INaCa currents increased (orange vs. blue trace, lower panel).
The increase in the INaK current was small compared to the 30%
increase in the magnitude of the INaCa exchanger current.
As seen in Figure 7, there was a concomitant raise in the dias-
tolic Cai and in the Cai transients in tandem with the increase in
Nai when the stimulations were applied until SS. To isolate the
effect of the increase in Nai, we started with the WR model sta-
bilized at 1Hz and instantaneously changed Nai to that of the
SS WT model (Figure 8B, black to blue traces). The model was
then instantaneously returned to the WT model (Figure 8B, blue
to orange traces). The changes in APD90, INaK, and INaCa were
comparable to those in Figure 8A. This indicates that, when Nai
was increased, the reverse mode of INaCa provided the main
increase in the outward current that caused the shortening of the
APD90.
A possible contribution of the increase in window current in
the effects of the mutation was tested in the model at steady-
state at 1Hz. The diastolic membrane voltage in the WT situa-
tion was −85.9mV and the threshold for stimulation was 21.4
pA/pF, whereas in the WR situation, they were −85.5mV and
20.8 pA/pF, respectively. Thus, there was a 0.4mV depolariza-
tion and a 2.8% decrease in stimulation threshold. Further, when
the window current of the WR model was made identical to that
in the WT model, by suppressing any changes in steady-state
activation and inactivation curves, the diastolic membrane volt-
age was −85.7mV and stimulation threshold 21.3 pA/pF. Thus,
although slightly, the window current appeared to increase cell
excitability.
DISCUSSION
We biophysically characterized a novel LQT3 mutation (Q1476R)
found in a previously symptomatic 34-year-old female with a
classic LQT3 ECG phenotype. The Q1476 residue is a highly
conserved amino acid in all Na+ channels (Figure 2) through-
out evolution, from humans to zebra fish. Interestingly, a second
highly conserved Q residue (Q1475) (Figure 2) was found imme-
diately upstream from Q1476. These two residues were located in
the inactivation gate upstream from the IFM motif. Given their
location, they are likely to play a role in the inactivation process.
Moreover, the Q1489H missense substitution on SCN1A encod-
ing the Nav1.1 neuronal voltage-gated Na+ channel (the Q1475
homolog in Nav1.5) is highly expressed in the central nervous
system, including the retina, and is found in patients with famil-
ial hemiplegic migraine (FHM, Figure 2B) (Vahedi et al., 2009).
Unfortunately, no biophysical characterization has been reported
for this mutation. We can speculate that a gain-of-function due to
this mutation may be the cause of FHM.
The present paper provides support for the concept that the
increase in the window current and the increase in the TTX sensi-
tive persistent current due to the LQT3 mutation (Q1476R) cause
LQTS. This is consistent with all studies indicating that muta-
tions in SCN5A causing LQTS are related to a gain-of-function
(Schwartz et al., 2012).
The treatment with 50μM of mexiletine importantly reduced
the INap observed on Q1476R mutant channels. This might
explain the beneficial effects of mexiletine treatment on the
patient. Unfortunately, the nausea due to mexiletine have
imposed the discontinuation of the treatment.
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FIGURE 7 | In silico simulation of heterozygous cardiomyocytes carrying
the Q1476R mutation. (A) The three columns correspond to different
stimulation frequencies indicated at the top of the figure. From top to bottom:
the action potential (AP), the fast sodium current (INa), the persistent sodium
current (INap), and cytosolic [Ca2+] (Cai). Under column 0.5Hz, traces at SS
are superimposed: trace a: WT at 1Hz (black), trace b: WT at 0.5Hz
(magenta), trace c: WR (1/2 WT + 1/2 Q1476R) at 1Hz (orange), and trace d:
WR at 0.5Hz (green). Under column 1Hz, trace a is WT at SS at 1Hz, trace b
is the subsequent AP after changing the model to WR, and trace c is the SS
in WR at 1Hz. Under column 1.5Hz, trace a is WT at SS at 1.5Hz, trace b is
the subsequent AP after changing the model to WR, and trace c is the SS in
WR at 1.5Hz. (B) Model tests of the role of Nai in determining APD90.
Instead of running the model until SS, Nai is changed instantaneously to its
SS value. Left panel, trace a shows the SS AP in WT at 1Hz. Trace b shows
the subsequent AP recorded after changing Nai to the value previously
observed at SS in the WT model at 0.5Hz (9.84mmol/L). Trace c shows the
subsequent AP recorded from the model after simultaneously setting the
model to WR and changing Nai to the value for WR at 1Hz at SS
(12.92mmol/L). Trace d shows the next AP recorded after changing Nai to the
value previously observed at SS in WR at 0.5Hz (10.95mmol/L). Middle
panel, trace a shows the SS AP in WR at 1Hz. Trace b shows the subsequent
AP recorded after changing Nai to its value previously observed at SS in the
WT model at 1Hz (11.94mmol/L). Trace c is the subsequent AP recorded
from the model after setting the model to WT. Right panel: Trace a shows the
SS AP in WR at 1.5Hz. Trace b shows the subsequent AP recorded after
changing Nai to the value previously observed at SS in the WT model at
1.5Hz (13.59mmol/L). Trace c shows the subsequent AP recorded from the
model after setting the model to WT.
Table 2 | APD90, Nai, and diastolic Cai at steady state recorded in the
model during 1- and 1.5-Hz stimulation.
Stimulation
frequency
Parameter WT WR first AP WR
1Hz APD90 (ms) 454 587 513
Nai (mmol/L) 11.94 11.94 12.92
Diastolic Cai (μmol/L) 0.109 0.109 0.135
APD90 in Nai tests (ms) 451 582
1.5Hz APD90 (ms) 392 471 436
Nai (mmol/L) 13.59 13.59 14.57
Diastolic Cai (μmol/L) 0.179 0.177 0.221
APD90 in Nai tests (ms) 396 484
As expected from its localization, the mutation impacts the
inactivation process. The Q1476Rmutation resulted in a depolar-
izing shift of inactivation, which tended to increase the overlap of
activation and inactivation gating (Figure 5). At voltages within
this overlap region, Na+ channels are partially but not fully
inactivated, thus increasing the potential for persistent window
Table 3 | Effect of bradycardia on APD90, Nai, and diastolic Cai at
steady state.
WT at WT at WR at WR at
1Hz 0.5Hz 1Hz 0.5Hz
APD90 (ms) 454 558 513 705
Nai (mmol/L) 11.94 9.84 12.92 10.95
Diastolic Cai (μmol/L) 0.109 0.057 0.135 0.071
APD90 in Nai test (ms) 542 515 683
currents (Attwell et al., 1979). At −50mV, the peak window
current probability predicts that a small percentage (0.1%) of
the mutant channels will be persistently activated. The resulting
inward Na+ current at resting membrane potentials could depo-
larize cardiac myocytes, leading to an increase in their excitability.
The increase in persistent current is not surprising as the muta-
tion is localized in the inactivation gate (DIII-DIV linker). The
effect of this mutation on the inactivation process would be a
decrease of the probability for channels to enter an inactivated
state. Consequently, a small amount of Nav1.5 Q1476R channels
will not inactivate after the rapid activation. Similar mechanisms
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FIGURE 8 | Time course of INaK and INaCa and summary of SS APD90
and Nai values. (A,B) Analysis of the contribution of INap, INaK, and INaCa
to APD90 changes. (A) The black traces (a) show the SS AP and currents in
WT at 1Hz. The blue traces (b) show the subsequent AP and currents
recorded after introducing the heterozygous Q1476R mutation. The orange
traces (c) were obtained after reaching the SS. (B) The black traces (a) show
AP and currents for the WR model stabilized at 1Hz. The blue traces (b)
were obtained when Nai was instantanously set to Nai of the SS WT
model. The orange traces (c) were obtained when switching to the WT
model. (C) Summary of APD90 and Nai values at SS at three stimulation
frequencies (0.5, 1, and 1.5Hz) and in the WT and WR models. The green
arrows indicate the transitions due to bradycardia, the red arrow those due
to tachycardia. The magenta arrows indicate the effect of passing from the
WT to WR condition at each frequency.
are believed to underlie the increased excitability of sensory neu-
rons harboring inherited human pain disorder mutations that
produce shifts in Nav1.7 activation and inactivation of similar
polarity and magnitude as those observed in the present study
(Harty et al., 2006; Rush et al., 2006; Dib-Hajj et al., 2010).
The in silico model confirmed the arrhythmogenic potential
of the Q1476R mutation. When the model was changed to the
heterozygous mutated paradigm, there was an immediate effect
that prolonged APD90. Continued stimulation caused a partial
reversion of this effect when SS was reached. At the same time,
both Nai and Cai increased. Figure 8C summarizes the effects
of the mutation combined with the heart rate on APD90 and
Nai. At SS, the accumulation of Na+ ions, related both to an
elevated frequency and to the presence of the mutation, tended
to shorten APD90. This would in turn tend to moderate the
LQT effect of the mutation at elevated heart rates such as under
effort or moderate stress. The gain-of-function due to a persistent
FIGURE 9 | Simulation of an interval variations paradigm known to
trigger EADs and Torsades de Pointes. From SS at 0.5Hz, a series of 40
stimulations were applied at 666ms intervals. Then, a combination of a
1666ms interval plus a couple of stimulations at 666ms interval was
applied twice (panel A). The action potentials produced by model for the
last 12 s of the protocol are shown in (B). While the WT model (black line)
shows a separate AP in response to each stimulation, the WR model
APD90 (magenta line) was longer than the 666ms interval, causing a
bigeminal aspect: every second AP is smaller and shorter. After the pauses,
EADs were present in the WR model only (arrows).
Na+ current may thus protect against arrhythmogenesis related
to a limited increase in heart rate. However, as was seen in the
model, an overload of Cai stores may appear at higher rates
and may trigger arrhythmias (Christe et al., 2008). Our data
are consistent with published experimental and model studies
(Pieske and Houser, 2003; Noble and Noble, 2006; Undrovinas
et al., 2006; Soliman et al., 2012). When combined with elevated
Ca2+ entry under adrenergic stress, arrhythmias may appear due
to early or late after-depolarizations. Under elevated Cai con-
ditions, a decrease in the L-type Ca2+ current ought to take
place due to the decrease in the transmembrane [Ca2+] gradient
and to the accelerated decay by calcium-dependent inactiva-
tion. Nevertheless, its contribution to the overall effect should be
minor. The slowly activating potassium current IKs was shown
to be increased by elevation of Cai, as due to a relief of KCNQ1
inactivation by calmodulin in a Ca2+ dependent way (Ghosh
et al., 2006). This feature was absent in the model. Such an
effect would enhance the frequency-dependent effect observed
in the model, resulting into a further shortening of the AP at
high frequencies that would be larger in the WR than in the WT
situation.
A combination of interval variations known to trigger EADs
and torsades de pointes (El-Sherif et al., 1999; Viswanathan and
Rudy, 1999; Tan et al., 2006) has been tested in the model. EADs
appeared in theWR condition while theWT remained unaffected
(Figure 9). This is consistent with emotional stress and exercise as
known triggers of arrhythmias in LQT3 (Schwartz et al., 2001).
Conversely, bradycardia causes a lower Nai and a lengthen-
ing of APD, which are well-known features of bradycardia (Faber
and Rudy, 2000). Changes in diastolic Cai and Cai transients
are also observed. Each of these may change the magnitude of
ionic currents and exchangers. Elevated Nai is known to cause
an activation of the Na/K ATPase pump and an increase in the
reverse mode Na-Ca exchanger current. Both of these processes
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may shorten APD (Armoundas et al., 2003), as well as the increase
in Ca2+-dependent inactivation of the Ca2+ current due to ele-
vated Cai (Carmeliet, 2006). Our simulations showed that most
of the APD changes were due to changes in Nai, mainly through
a lower INaCa. The LQT effect of the mutation is likely to be
more serious at low heart rates, as illustrated in our simulations
where APD90 reached very critical values around 700ms in the
heterozygous model. Thus, the carrier of the mutation may be
preferentially sensitive to factors triggering arrhythmias when at
rest, which is a characteristic of LQT3 syndrome. During activ-
ity, APD shortening, due to increased entry of Na+ ions, may
protect the carrier against arrhythmias. These results should be
qualitatively reproduced in other models of human ventricular
myocytes, since the basic features of the Nai homeostasis ought to
obey to the same constraints. Furthermore, the functional conse-
quences, as analyzed here for mutation Q1476R, may in principle
be extended for other LQT3 mutations involving an increase in
persistent and window currents. The intracellular Na+ overload,
as related to the gain-of-function in Na+ channels, is proper
to LQT3 and is unlikely in LQT syndromes related to potas-
sium channel dysfunctions. This might be taken into account for
personalized prevention and therapy of LQT3 patients.
LIMITATIONS OF THE IN SILICO MODEL
The basic TNNP model assumed no fraction of INap. However,
the magnitudes of the INaCa, INaK, and Na+ background cur-
rents had been adjusted to account for the high Nai in ventricular
human myocytes. The present modified model may thus have an
overall excess of Na+ entry. A late Na+ current was added to the
model in the WT condition, and its magnitude was limited to
one-third of the fraction of the peak Na+ current found in tsA201
cells. This caused the APD90 in theWT configuration to be 454ms
vs. 325ms in the basic TNNP model, whereas values of ∼370 or
400ms have been reported by Li et al. (1998, 1999) in human ven-
tricular myocytes. As a result, the effects of themutationmay have
been overemphasized in the present simulations.
Several ion channels have been shown to be modulated by
intracellular Ca2+, either directly or through intracellular effec-
tors (e.g., calmodulin), such modulations were not included
in the model. Several additional channels (e.g., stretch-sensitive
channels) found in mammalian ventricular myocytes were nei-
ther included. A number of investigations in human ventricular
myocytes are still needed to document their formulation.
Lastly, this model assumes that no changes other than those
due to the Na+ channel mutation took place. There are reasons
to doubt this, since a permanent Na+ and Ca2+ overload, as seen
here in the WR model, are known triggers of remodeling of ion
channel densities and excitation-contraction coupling efficiency
in cardiac cells, which may have taken place over the long-term in
carriers of the mutation.
ACKNOWLEDGMENTS
This study was supported by grants from the Heart and Stroke
Foundation of Quebec (HSFQ), the Canadian Institutes of
Health Research (CIHR, MT-13181), and the Heart and Stroke
Foundation of Ontario (T6730).
REFERENCES
Amin, A. S., Asghari-Roodsari, A., and
Tan, H. L. (2010). Cardiac sodium
channelopathies. Pflugers Arch. 460,
223–237. doi: 10.1007/s00424-009-
0761-0
Armoundas, A. A., Hobai, I. A.,
Tomaselli, G. F., Winslow, R. L.,
and O’Rourke, B. (2003). Role
of sodium-calcium exchanger in
modulating the action potential
of ventricular myocytes from
normal and failing hearts. Circ.
Res. 93, 46–53. doi: 10.1161/01.
RES.0000080932.98903.D8
Attwell, D., Cohen, I., Eisner, D., Ohba,
M., and Ojeda, C. (1979). The
steady state TTX-sensitive (“win-
dow”) sodium current in cardiac
Purkinje fibres. Pflugers Arch. 379,
137–142. doi: 10.1007/BF00586939
Carmeliet, E. (2006). Action potential
duration, rate of stimula-
tion, and intracellular sodium.
J. Cardiovasc. Electrophysiol.
17(Suppl. 1), S2–S7. doi:
10.1111/j.1540-8167.2006.00378.x
Christe, G., Chahine, M., Chevalier,
P., and Pasek, M. (2008). Changes
in action potentials and intracellu-
lar ionic homeostasis in a ventric-
ular cell model related to a per-
sistent sodium current in SCN5A
mutations underlying LQT3. Prog.
Biophys. Mol. Biol. 96, 281–293. doi:
10.1016/j.pbiomolbio.2007.07.023
Dib-Hajj, S. D., Cummins, T. R.,
Black, J. A., and Waxman, S. G.
(2010). Sodium channels in nor-
mal and pathological pain. Annu.
Rev. Neurosci. 33, 325–347. doi:
10.1146/annurev-neuro-060909-
153234
El-Sherif, N., Caref, E. B., Chinushi, M.,
and Restivo, M. (1999). Mechanism
of arrhythmogenicity of the short-
long cardiac sequence that pre-
cedes ventricular tachyarrhythmias
in the long QT syndrome. J. Am.
Coll. Cardiol. 33, 1415–1423. doi:
10.1016/S0735-1097(98)00700-1
Faber, G. M., and Rudy, Y.
(2000). Action potential
and contractility changes in
[Na(+)](i) overloaded cardiac
myocytes: a simulation study.
Biophys. J. 78, 2392–2404. doi:
10.1016/S0006-3495(00)76783-X
Fink, M., and Noble, D. (2009).
Markov models for ion channels:
versatility versus identifiability
and speed. Philos. Trans. A Math.
Phys. Eng. Sci. 367, 2161–2179. doi:
10.1098/rsta.2008.0301
Gellens, M. E., George, A. L. Jr.,
Chen, L. Q., Chahine, M., Horn,
R., Barchi, R. L., et al. (1992).
Primary structure and functional
expression of the human cardiac
tetrodotoxin-insensitive voltage-
dependent sodium channel. Proc.
Natl. Acad. Sci. U.S.A. 89, 554–558.
doi: 10.1073/pnas.89.2.554
Ghosh, S., Nunziato, D. A., and Pitt,
G. S. (2006). KCNQ1 assembly and
function is blocked by long-QT
syndrome mutations that disrupt
interaction with calmodulin. Circ.
Res. 98, 1048–1054. doi: 10.1161/01.
RES.0000218863.44140.f2
Gosselin-Badaroudine, P., Keller, D. I.,
Huang, H., Pouliot, V., Chatelier, A.,
Osswald, S., et al. (2012). A pro-
ton leak current through the car-
diac sodium channel is linked to
mixed arrhythmia and the dilated
cardiomyopathy phenotype. PLoS
ONE 7:e38331. doi: 10.1371/jour-
nal.pone.0038331
Hamill, O. P., Marty, A., Neher, E.,
Sakmann, B., and Sigworth, F. J.
(1981). Improved patch-clamp
techniques for high-resolution
current recording from cells
and cell-free membrane patches.
Pflugers Arch. 391, 85–100. doi:
10.1007/BF00656997
Harty, T. P., Dib-Hajj, S. D., Tyrrell,
L., Blackman, R., Hisama, F. M.,
Rose, J. B., et al. (2006). Na(V)1.7
mutant A863P in erythromelal-
gia: effects of altered activation
and steady-state inactivation
on excitability of nociceptive
dorsal root ganglion neurons.
J. Neurosci. 26, 12566–12575. doi:
10.1523/JNEUROSCI.3424-06.2006
Huang, H., Priori, S. G., Napolitano,
C., O’Leary, M. E., and Chahine,
M. (2011). Y1767C, a novel SCN5A
mutation, induces a persistent
Na+ current and potentiates
ranolazine inhibition of Nav1.5
channels. Am. J. Physiol. Heart
Circ. Physiol. 300, H288–H299. doi:
10.1152/ajpheart.00539.2010
Iyer, V., Mazhari, R., and Winslow,
R. L. (2004). A computational
model of the human left-
ventricular epicardial myocyte.
Biophys. J. 87, 1507–1525. doi:
10.1529/biophysj.104.043299
Jurman, M. E., Boland, L. M., Liu,
Y., and Yellen, G. (1994). Visual
identification of individual trans-
fected cells for electrophysiology
using antibody-coated beads.
Biotechniques 17, 876–881.
Li, G. R., Feng, J., Yue, L., and Carrier,
M. (1998). Transmural heterogene-
ity of action potentials and Ito1 in
myocytes isolated from the human
www.frontiersin.org October 2013 | Volume 4 | Article 126 | 11
Moreau et al. Sodium overload attenuate LQT3 arrhythmias
right ventricle. Am. J. Physiol. 275,
H369–H377.
Li, G. R., Yang, B., Feng, J., Bosch,
R. F., Carrier, M., and Nattel, S.
(1999). Transmembrane ICa con-
tributes to rate-dependent changes
of action potentials in human ven-
tricular myocytes. Am. J. Physiol.
276, H98–H106.
Margolskee, R. F., McHendry-Rinde,
B., and Horn, R. (1993). Panning
transfected cells for electrophysi-
ological studies. Biotechniques 15,
906–911.
Moreau, A., Keller, D. I., Huang, H.,
Fressart, V., Schmied, C., Timour,
Q., et al. (2012). Mexiletine dif-
ferentially restores the trafficking
defects caused by two brugada syn-
dromemutations. Front. Pharmacol.
3:62. doi: 10.3389/fphar.2012.00062
Nagatomo, T., Fan, Z., Ye, B.,
Tonkovich, G. S., January, C.
T., Kyle, J. W., et al. (1998).
Temperature dependence of early
and late currents in human cardiac
wild-type and long Q-T DeltaKPQ
Na+ channels. Am. J. Physiol. 275,
H2016–H2024.
Noble, D., and Noble, P. J. (2006). Late
sodium current in the pathophysiol-
ogy of cardiovascular disease: con-
sequences of sodium-calcium over-
load. Heart 92(Suppl. 4), iv1–iv5.
doi: 10.1136/hrt.2005.078782
Pasek, M., Simurda, J., Orchard, C. H.,
and Christe, G. (2008). A model of
the guinea-pig ventricular cardiac
myocyte incorporating a transverse-
axial tubular system. Prog. Biophys.
Mol. Biol. 96, 258–280. doi:
10.1016/j.pbiomolbio.2007.07.022
Pieske, B., and Houser, S. R.
(2003). [Na+]i handling in
the failing human heart.
Cardiovasc. Res. 57, 874–886. doi:
10.1016/S0008-6363(02)00841-6
Priebe, L., and Beuckelmann, D. J.
(1998). Simulation study of cellu-
lar electric properties in heart fail-
ure. Circ. Res. 82, 1206–1223. doi:
10.1161/01.RES.82.11.1206
Rush, A. M., Dib-Hajj, S. D., Liu,
S., Cummins, T. R., Black, J. A.,
and Waxman, S. G. (2006). A
single sodium channel mutation
produces hyper- or hypoexcitabil-
ity in different types of neurons.
Proc. Natl. Acad. Sci. U.S.A. 103,
8245–8250. doi: 10.1073/pnas.
0602813103
Schwartz, P. J., Crotti, L., and
Insolia, R. (2012). Long-QT
syndrome: from genetics to
management. Circ. Arrhythm.
Electrophysiol. 5, 868–877. doi:
10.1161/CIRCEP.111.962019
Schwartz, P. J., Priori, S. G., Spazzolini,
C., Moss, A. J., Vincent, G.
M., Napolitano, C., et al.
(2001). Genotype-phenotype
correlation in the long-QT syn-
drome: gene-specific triggers
for life-threatening arrhythmias.
Circulation 103, 89–95. doi:
10.1161/01.CIR.103.1.89
Soliman, D., Wang, L., Hamming, K.
S., Yang, W., Fatehi, M., Carter,
C. C., et al. (2012). Late sodium
current inhibition alone with
ranolazine is sufficient to reduce
ischemia- and cardiac glycoside-
induced calcium overload and
contractile dysfunction mediated
by reverse-mode sodium/calcium
exchange. J. Pharmacol. Exp.
Ther. 343, 325–332. doi:
10.1124/jpet.112.196949
Tan, H. L., Bardai, A., Shimizu, W.,
Moss, A. J., Schulze-Bahr, E., Noda,
T., et al. (2006). Genotype-specific
onset of arrhythmias in congen-
ital long-QT syndrome: possible
therapy implications. Circulation
114, 2096–2103. doi: 10.1161/
CIRCULATIONAHA.106.642694
Tang, Q., Ma, J., Zhang, P., Wan,
W., Kong, L., and Wu, L. (2012).
Persistent sodium current and
Na(+)/H (+) exchange con-
tributes to the augmentation
of the reverse Na(+)/Ca (2+)
exchange during hypoxia or acute
ischemia in ventricular myocytes.
Pflugers Arch. 463, 513–522. doi:
10.1007/s00424-011-1070-y
Ten Tusscher, K. H., Bernus, O.,
Hren, R., and Panfilov, A. V.
(2006). Comparison of electro-
physiological models for human
ventricular cells and tissues. Prog.
Biophys. Mol. Biol. 90, 326–345. doi:
10.1016/j.pbiomolbio.2005.05.015
Ten Tusscher, K. H., Noble, D., Noble,
P. J., and Panfilov, A. V. (2004).
A model for human ventricular
tissue. Am. J. Physiol. Heart Circ.
Physiol. 286, H1573–H1589. doi:
10.1152/ajpheart.00794.2003
Undrovinas, A. I., Belardinelli, L.,
Undrovinas, N. A., and Sabbah, H.
N. (2006). Ranolazine improves
abnormal repolarization and
contraction in left ventricular
myocytes of dogs with heart failure
by inhibiting late sodium cur-
rent. J. Cardiovasc. Electrophysiol.
17(Suppl. 1), S169–S177. doi:
10.1111/j.1540-8167.2006.00401.x
Vahedi, K., Depienne, C., Le Fort,
D., Riant, F., Chaine, P., Trouillard,
O., et al. (2009). Elicited repetitive
daily blindness: a new phenotype
associated with hemiplegicmigraine
and SCN1A mutations. Neurology
72, 1178–1183. doi: 10.1212/01.wnl.
0000345393.53132.8c
Viswanathan, P. C., and Rudy, Y.
(1999). Pause induced early after-
depolarizations in the long QT
syndrome: a simulation study.
Cardiovasc. Res. 42, 530–542. doi:
10.1016/S0008-6363(99)00035-8
Wong, J. A., Gula, L. J., Klein, G.
J., Yee, R., Skanes, A. C., and
Krahn, A. D. (2010). Utility of
treadmill testing in identification
and genotype prediction in long-
QT syndrome. Circ. Arrhythm.
Electrophysiol. 3, 120–125. doi:
10.1161/CIRCEP.109.907865
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 27 June 2013; accepted: 11
September 2013; published online: 01
October 2013.
Citation: Moreau A, Krahn AD,
Gosselin-Badaroudine P, Klein GJ,
Christé G, Vincent Y, Boutjdir M and
Chahine M (2013) Sodium overload due
to a persistent current that attenuates
the arrhythmogenic potential of a novel
LQT3 mutation. Front. Pharmacol.
4:126. doi: 10.3389/fphar.2013.00126
This article was submitted to
Pharmacology of Ion Channels and
Channelopathies, a section of the journal
Frontiers in Pharmacology.
Copyright © 2013 Moreau, Krahn,
Gosselin-Badaroudine, Klein, Christé,
Vincent, Boutjdir and Chahine. This is
an open-access article distributed under
the terms of the Creative Commons
Attribution License (CC BY). The use,
distribution or reproduction in other
forums is permitted, provided the origi-
nal author(s) or licensor are credited and
that the original publication in this jour-
nal is cited, in accordance with accepted
academic practice. No use, distribution
or reproduction is permitted which does
not comply with these terms.
Frontiers in Pharmacology | Pharmacology of Ion Channels and Channelopathies October 2013 | Volume 4 | Article 126 | 12
Moreau et al. Sodium overload attenuate LQT3 arrhythmias
APPENDIX
Equations used in the TNNP model:
WT is a variable taking three possible values:WT= 1 for a pure
WT cell, WT = 0.5 for the heterozygous condition and WT = 0
when all channels are mutated.
gNaWT = WT · 14.838
gNaQ1476R = (1 − WT) · 14.838 · (1 − 0.02)
iNafastWT = gNaWT · mWT3 · hWT · (V − ENa)
minfWT = 1
1 + e V + 53.6−7.4
iNafastQ1476R = gNaQ1476R · mQ1476R3 · hQ1476R · (V − ENa)
minfQ1476R = 1









1 + e V + 86.54.4
hinfQ1476R
1








gNapsWT = WT · 14.838 · 0.0019
fm
fm = 3
gNapsQ1476R = (1 − WT) · 14.838 · (1 − 0.02) · 0.0033
fm
iNapsWT = gNapsWT · minfWT3 · (V − ENa)
iNapsQ1476R = gNapsQ1476R · minfQ1476R3 · (V − ENa)
iNa = iNafastWT + iNafastQ1476R + iNapersWT + NapersQ1476R
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